Build one diligence process that connects strategy, finance, legal, compliance, antitrust, tax, clinical quality, credentialing, workforce, operations, information technology, cybersecurity, insurance, real estate, and reputation. Separate workstreams still need a shared issue log because one finding can change the economics or structure of the entire arrangement.

Assess competition early with experienced counsel. Transactions and collaborations can raise different concerns depending on market structure, referral relationships, information sharing, purchasing, labor, and the ability to limit rivals' access. The DOJ and FTC merger guidelines describe agency analytical frameworks, but they do not replace fact-specific legal analysis.

Review financial relationships and federal health program exposure. Compensation, ownership, referrals, shared savings, marketing, management fees, free services, and technology support may implicate the physician self-referral law, Anti-Kickback Statute, Civil Monetary Penalties Law, billing rules, or other requirements. Safe harbors or exceptions require careful satisfaction of their terms.

For tax-exempt hospitals, connect expansion to charitable purpose, community benefit, and the community health needs assessment and implementation strategy. Document how the arrangement affects medically underserved populations, financial assistance, community resources, and access. A project can be strategically attractive while failing to address the needs the organization has publicly prioritized.

Test the operating assumptions. Validate volume, payer mix, referral behavior, clinician availability, licensure, capacity, capital needs, technology integration, ramp time, and downside cases. Review pending litigation, audits, quality events, exclusions, cybersecurity incidents, debt restrictions, and change-of-control provisions.

Use stage gates. Do not allow a public deadline or sunk advisory cost to force a deal through unresolved issues. The board should know which findings are closed, mitigated, priced, accepted, or still capable of changing the recommendation.

Create a balanced scorecard tied to the original expansion thesis. Include access, quality, equity, patient experience, workforce, compliance, strategic capability, and financial performance. Referral volume or revenue alone can reward activity that does not improve outcomes or community benefit.

Define attribution and baselines. Agree on how patients, savings, costs, quality events, capital, and shared outcomes will be measured. Document data sources, exclusions, timing, risk adjustment, and dispute resolution. A partnership cannot manage value if the parties calculate it differently.

Release capital in stages when feasible. Tie investment to licensing, staffing, technology, volume, quality, and integration milestones. Update the forecast with actual results and require a recovery plan when assumptions fail. Do not hide underperformance by repeatedly moving the original baseline.

Review portfolio interactions. Multiple partnerships may compete for the same clinicians, patients, technology resources, or capital. They may also create inconsistent terms or overlapping territories. Enterprise leaders need a portfolio view of obligations, performance, concentration, and cumulative risk.

Plan for renewal, restructuring, and exit at the beginning. Address ownership changes, key-person departure, persistent quality failure, insolvency, regulatory change, cyber incidents, data return, patient continuity, workforce transition, brand removal, and dispute. A responsible exit protects patients and preserves records even when the commercial relationship ends.

Report to the board at a decision-making cadence. Highlight variance from thesis, unresolved safety or compliance issues, capital exposure, partner dependencies, corrective-action status, and upcoming choices. Celebration belongs at launch; governance belongs throughout the life of the partnership.